Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
All groups:
- People diagnosed with one of the following conditions: Ewing sarcoma, synovial sarcoma, acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, or myelodysplasia
- The patient's cancer specialist has no objection to the tissue collection or reimplantation procedure involved in this trial
- Informed consent has been given to participate
Group 1 (ovarian tissue freezing/storage):
- People aged 18 to 37 at the time of ovarian tissue freezing
- A request for ovarian tissue freezing has been made at the specific laboratory at IRCCS AOUBO
Group 2 (ovarian tissue already stored):
- People aged 18 or older
- Ovarian tissue has already been collected and stored at the specific laboratory at IRCCS AOUBO
Group 3 (reimplantation of stored ovarian tissue):
- People aged 18 or older
- A request for reimplantation of stored ovarian tissue has been made at the specific laboratory at IRCCS AOUBO
- Early menopause or irregular periods are present
Who may not be able to join:
Groups 1 and 3:
- People for whom laparoscopic surgery (a type of keyhole surgery) is not considered safe
- People who test positive for HIV, hepatitis B, hepatitis C, syphilis, or who have an abnormal cervical screening result
- People whose cancer affects the ovaries, or where the tissue to be reimplanted shows signs of cancer
Group 2:
- No exclusion criteria apply to this group
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Renato Seracchioli, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: +390512143944
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection rate of cancer cells on cryopreserved ovarian tissue
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.